HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

polymyxin B nonapeptide

structure in first source
Also Known As:
PMBN; polymyxin B cyclononapeptide; Polymyxin B1, 1-de(N2-(6-methyl-1-oxooctyl)-L-2,4-diaminobutanoic acid)-
Networked: 14 relevant articles (0 outcomes, 2 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ishihara, Kazuhiko: 3 articles (12/2011 - 04/2009)
2. Kitagawa, Yuko: 3 articles (12/2011 - 04/2009)
3. Ueda, Masakazu: 3 articles (12/2011 - 04/2009)
4. Garg, Sanjay: 2 articles (01/2020 - 01/2019)
5. McCluskey, Adam: 2 articles (01/2020 - 01/2019)
6. Page, Stephen W: 2 articles (01/2020 - 01/2019)
7. Pi, Hongfei: 2 articles (01/2020 - 01/2019)
8. Trott, Darren J: 2 articles (01/2020 - 01/2019)
9. Venter, Henrietta: 2 articles (01/2020 - 01/2019)
10. Konno, Tomohiro: 2 articles (12/2011 - 05/2009)

Related Diseases

1. Infections
2. Soft Tissue Infections
3. Otitis Externa
4. Neoplasms (Cancer)
5. Acute Kidney Injury (Acute Renal Failure)

Related Drugs and Biologics

1. polymyxin B nonapeptide
2. Edetic Acid (EDTA)
3. Robenidine
4. Linezolid (Zyvox)
5. Paclitaxel (Taxol)
6. Anti-Bacterial Agents (Antibiotics)
7. Frankincense
8. Cyclosporine (Ciclosporin)
9. Biomarkers (Surrogate Marker)
10. Interleukin-2 Receptors (IL 2 Receptor)

Related Therapies and Procedures

1. Therapeutics
2. Intraperitoneal Injections